is reporting from
Member
NP Rank:
NP Rank:
Canadian pharmaceutical firm Replicor has discovered a compound to treat influenza infections that could potentially be used to fight the deadly H5N1 bird flu, the company's chief executive officer told AFP.
Most RecentMost Recommended Comments (0)